NBIX - Neurocrine Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

NBIX is currently covered by 25 analysts with an average price target of $135.36. This is a potential upside of $27.67 (25.69%) from yesterday's end of day stock price of $107.69.

Neurocrine Biosciences's activity chart (see below) currently has 315 price targets and 300 ratings on display. The stock rating distribution of NBIX is 71.43% BUY and 28.57% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 80.03% with an average time for these price targets to be met of 268.32 days.

Highest price target for NBIX is $219, Lowest price target is $114, average price target is $158.5.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 22-Apr-2025. First documented stock forecast 04-Feb-2015.

Currently out of the existing stock ratings of NBIX, 75 are a BUY (71.43%), 30 are a HOLD (28.57%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$168

$61.27 (57.41%)

$185

9 days ago
(22-Apr-2025)

13/23 (56.52%)

$66.26 (65.13%)

528

Hold

$138

$31.27 (29.30%)

16 days ago
(15-Apr-2025)

0/1 (0%)

$41.84 (43.51%)

Hold

$137

$30.27 (28.36%)

$148

17 days ago
(14-Apr-2025)

17/19 (89.47%)

$42.11 (44.38%)

117

Buy

$137

$30.27 (28.36%)

$162

27 days ago
(04-Apr-2025)

3/6 (50%)

$41.35 (43.23%)

262

Buy

$184

$77.27 (72.40%)

$181

1 months 5 days ago
(26-Mar-2025)

15/18 (83.33%)

$69.55 (60.77%)

332

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is NBIX (Neurocrine Biosciences) average time for price targets to be met?

On average it took 268.32 days on average for the stock forecasts to be realized with a an average price target met ratio 80.03

Which analyst has the current highest performing score on NBIX (Neurocrine Biosciences) with a proven track record?

DANIELLE BRILL

Which analyst has the most public recommendations on NBIX (Neurocrine Biosciences)?

Danielle Brill works at RAYMOND JAMES and has 7 price targets and 7 ratings on NBIX

Which analyst is the currently most bullish on NBIX (Neurocrine Biosciences)?

Jay Olson with highest potential upside - $112.27

Which analyst is the currently most reserved on NBIX (Neurocrine Biosciences)?

Thomas Wei with lowest potential downside - -$69.25

Neurocrine Biosciences in the News

NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is an undervalued gem with solid fundamentals.

Enable social media cookies to share NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) is an undervalued gem with solid fundamentals. By Mill Chart Last update: Apr 9, 2025 Uncover the potential of NEUROCRINE BIOSCIENCES INC (NASDAQ:NBIX) as our stock screener’s choice for an undervalued stock. NBIX maintains a strong financial position and offers an appealing valuation. We’ll delve...

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?